CAS 361442-00-4
:(αS)-α[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid
Description:
The chemical substance known as "(αS)-α[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid" with CAS number 361442-00-4 is characterized by its complex tricyclic structure, which contributes to its unique chemical properties. This compound features a stereocenter, indicated by the (αS) designation, suggesting it has specific optical activity. The presence of a dimethylethoxycarbonyl group indicates that it has protective functional groups, which are often used in organic synthesis to shield reactive sites. The hydroxyl group at the 3-position enhances its potential for hydrogen bonding, influencing solubility and reactivity. Additionally, the acetic acid moiety suggests potential for acid-base interactions. Overall, this compound's intricate structure and functional groups make it of interest in medicinal chemistry and synthetic applications, where its stereochemistry and reactivity can be leveraged for specific biological activities or as intermediates in the synthesis of more complex molecules.
Formula:C17H27NO5
InChI:InChI=1S/C17H27NO5/c1-15(2,3)23-14(21)18-12(13(19)20)16-5-10-4-11(6-16)8-17(22,7-10)9-16/h10-12,22H,4-9H2,1-3H3,(H,18,21)(H,19,20)/t10?,11?,12-,16?,17?/m1/s1
InChI key:InChIKey=UKCKDSNFBFHSHC-ZEJPWUNMSA-N
SMILES:[C@@H](NC(OC(C)(C)C)=O)(C(O)=O)C12CC3(O)CC(C1)CC(C2)C3
Synonyms:- (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)acetic acid
- (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)aceticacid
- (2S)-[(tert-Butoxycarbonyl)amino](3-hydroxytricyclo[3.3.1.1<sup>3,7</sup>]decan-1-yl)ethanoic acid
- (S)-2-((tert-Butoxycarbonyl)amino)-2-((1R,3S,5R,7S)-3-hydroxyadamantan-1-yl)acetic acid
- (S)-N-Boc-3-hydroxyadamantylglycine
- (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.1(3,7)]decane-1-acetic acid
- (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid
- (αS)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.1<sup>3,7</sup>]decane-1-acetic acid
- Boc-3-Hydroxy-1-adamantyl-D-glycin
- N-tert-Butyloxycarbonyl-3-Hydroxy-1-Adamantyl-D-Glycine
- Saxagliptin Intermediate 3
- Tricyclo[3.3.1.13,7]decane-1-Acetic acid,.alpha.-[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxy-, (.alpha.S)-
- Tricyclo[3.3.1.13,7]decane-1-a acid, .alpha.-[[(1,1-dimethyleth no]-3-hydroxy-, (.alpha.S)-
- Tricyclo[3.3.1.13,7]decane-1-a acid, alpha-[[(1,1-dimethyleth no]-3-hydroxy-, (alphaS)-
- Tricyclo[3.3.1.13,7]decane-1-acetic acid,alpha-[[(1,1-dimethylethoxy)carbonyl]amino]-, (alphaS)-
- Tricyclo[3.3.1.1<sup>3,7</sup>]decane-1-acetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxy-, (αS)-
- (2S)-[(tert-Butoxycarbonyl)amino](3-hydroxytricyclo[3.3.1.13,7]decan-1-yl)ethanoic acid
- (αS)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid
- (αS)-α[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-acetic acid
- Boc-3-hydroxy-1-adamantyl-d-glycine
- Tricyclo[3.3.1.13,7]decane-1-acetic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-3-hydroxy-, (αS)-
- Boc-3-Hydroxy-1-adamantyl
- α‐{[(1,1‐Dimethylethoxy)‐carbonyl]‐amino}‐3‐hydroxy‐ tricyclo[3.3.113,7]decane‐1‐acetic acid
- Saxagliptin impurity F
- (S)-2-(Boc-amino)-2-(3-hydroxy-1-adamantanyl)acetic Acid
- Boc-3-Hydroxy-1-adamantyl-D-glycine(For export only)
- (S)-2-((tert-butoxycarbonyl)amino)-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)aceticacid
- Carbonyl]amino-3-hydroxy
- (2S)-[(tert-Butoxycarbonyl)amino]-2-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)acetic Acid
- R-isomer of SXG acid
- Boc-(R)-2-(3-Hydroxy-1-adamantyl)glycine
- Boc-3-Hydroxy-1-adamantyl-D-glycine USP/EP/BP
- Saxagliptin INT 3
- N-tert butoxycarbonyl-3-hydroxy-1-adamantine-D-glycine
- (S)-N-tert-Butyloxycarbonyl-3-HydroxyadaMantylglycine
- (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-aceticac
- Boc-3- hydroxy-1-amantadyl - D-glycine
- N- tert-butyloxy-3-hydroxy-1- adamantyl- D- glycine
- Saxaint-G
- Saxagliptin II
- ethoxy)carbonyl]aMino]-3-hydroxy-, (.alpha.S)-
- 2S-N-Boc-amino-(3-Hydroxy-adamantan-1-yl)-acetic acid
- Saxaint-I
- Vildagliptin interMediate D
- ( S ) -2 - ( ( tert - butoxycarbonyl ) amino ) -2 - ( ( 1r , 3R , 5R , 7S ) -3 - hydroxyadamantan - 1 - yl ) acetic a
- acetic acid
- (S)[[(1,1-dimethylethoxy)
- TIANFU-CHEM Boc-3-Hydroxy-1-adamantyl-D-glycine
- TRICYCLO[3.3.1.13,7]DECANE-1-ACETIC ACID,.ALPHA.-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-3-HYDROXY-
- (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-hydroxyadamantan-1-yl)aceticaci
- EOS-60797
- Tricyclo[3.3.1.13,7]decane-1-Acetic acid,.alpha.-[[(1,1-diMethyl
- (alphaS)-alpha-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-hydroxytricyclo[3.3.1.13,7]decane-1-
- Boc-3-Hydroxy-1-Adamantyl-D-Glycine / Saxagliptin Intermediate
- tricyclo[3.3.1.1]decane-1
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
(2S)-[(tert-Butoxycarbonyl)amino](3-hydroxytricyclo[3.3.1.13,7]decan-1-yl)ethanoic acid
CAS:Formula:C17H27NO5Purity:95%Color and Shape:SolidMolecular weight:325.4000(2S)-2-((Tert-Butoxycarbonyl)Amino)-2-(3-Hydroxyadamantan-1-yl)Acetic Acid
CAS:(2S)-2-((Tert-Butoxycarbonyl)Amino)-2-(3-Hydroxyadamantan-1-yl)Acetic AcidPurity:99% HPLCMolecular weight:325.40g/mol(2S)-[(tert-Butoxycarbonyl)amino]-2-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)acetic Acid
CAS:Color and Shape:NeatBoc-3-hydroxy-1-adamantyl-D-glycine
CAS:Controlled Product<p>Applications Boc-3-hydroxy-1-adamantyl-D-glycine is used in the preparation of a Saxagliptin intermediate.<br>References Hanson, R.L., et. al.: Adv. Scyn. Catal., 349, 1369 (2007)<br></p>Formula:C17H27NO5Color and Shape:NeatMolecular weight:325.4





